Company / EPS (Diluted)
GERON CORP EPS (Diluted) History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.27
FY2024
5-year range
-$0.36 / -$0.15
FY2020-FY2024
Trend
+22.9%
vs FY2023
Sector context
#56 of 204
Health Care
What the data says
At $-0.27, GERON CORP's eps (diluted) ranks #56 of 204 in the Health Care sector. EPS (Diluted) has fluctuated over the past 10 years, ranging from $-0.36 in FY2021 to $0.00 in FY2017.
Based on SEC 10-K filings.
-0.27 in FY2024.
Improved from $-0.28 to $-0.27 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#56 of 204 in Health CareTop 27% of 204This company -$0.27 Sector average -$0.98
▼
+72.4% above sector average
Key checks
Key Insights
- In FY2024, eps (diluted) increased 22.9% year-over-year.
- Ranks #56 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2017.
- Lowest eps (diluted) in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.27 | +22.9% |
| FY2023 | -$0.35 | -25.0% |
| FY2022 | -$0.28 | +22.2% |
| FY2021 | -$0.36 | -140.0% |
| FY2020 | -$0.15 | +16.7% |
| FY2019 | -$0.18 | +5.3% |
| FY2018 | -$0.19 | - |
| FY2017 | $0.00 | +100.0% |
| FY2016 | -$0.23 | +23.3% |
| FY2015 | -$0.30 | +44.4% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026